Drugs and Treatments for Autoimmune Diseases: Global Markets

October 20, 2011

Wellesley, Mass. – In a recent release, DRUGS AND TREATMENTS FOR AUTOIMMUNE DISEASES: GLOBAL MARKETS (HLC091A) from BCC Research (www.bccresearch.com), the global market for autoimmune treatments was valued at nearly $39 billion in 2011 and is forecast to be $55 billion in 2016, a compound annual growth rate (CAGR) of 7.2%.

The global market for autoimmune treatments can be broken down into three segments – pharmaceutical treatments, assistive therapy treatments, and diagnostic testing for autoimmune treatment.

The segment made up of pharmaceutical treatments was worth $35.8 billion in 2011 and in 2016 should be worth $50.6 billion, a CAGR of 7.2%.

The segment composed of assistive therapy treatments, worth $2 billion in 2011, should be worth nearly $2.9 billion in 2016, a CAGR of 7%.

The diagnostic testing for autoimmune treatment segment was worth $1.1 billion in 2011 and in 2016 is expected to be worth nearly $1.6 billion, a CAGR 7.1%.

Autoimmune diseases arise from an overactive immune response by the body against substances and tissues normally present in the body. An autoimmune reaction can be triggered by a foreign substance entering the body; an alteration of normal body substances through a virus, drug, sunlight, or radiation; a malfunctioning of cells that control antibody production within the body; and genetic predisposition.

The six leading autoimmune diseases at which most of the pharmaceuticals, diagnostic testing, and assistive therapies are directed are rheumatoid arthritis; type 1 diabetes; systemic lupus erythematosus; multiple sclerosis; inflammatory bowel syndrome, including ulcerative colitis and Crohn’s disease; and psoriasis.

Because autoimmune diseases are found in all global regions and it is estimated that one in five individuals suffers from some form of autoimmune disease, it is not surprising that there has been continued growth in this sector, and that market growth is likely to continue for the scope of this report and beyond. 

This report is an invaluable tool for business planners, acquisition specialists, licensing strategists, product managers, market research analysts, investing consultants, and others interested in the autoimmune market, its products, its participants, and its future.

To Contact us, click here  

Drugs and Treatments for Autoimmune Diseases: Global Markets( HLC091A )
Publish Date: Oct 2011    

Data and analysis extracted from this press release must be accompanied by a statement identifying BCC Research LLC as the source and publisher. For media inquiries, email press@bccresearch.com or visit www.bccresearch.com/media to request access to our library of market research.